OLIGONUCLEOTIDE-BASED TUNING OF PORE-FORMING PEPTIDES FOR INCREASING PORE SIZE, MEMBRANE AFFINITY, STABILITY, AND ANTIMICROBIAL ACTIVITY
20220033527 · 2022-02-03
Inventors
Cpc classification
C07K19/00
CHEMISTRY; METALLURGY
International classification
Abstract
Pore-forming peptides or proteins modified utilizing DNA nanotechnology, which provides definition and control of pore size, an increase in stability when inserted in a lipid membrane, and membrane affinity. Chemical modifications are easily made on the compound through hybridization to the oligonucleotide attached to the peptide or protein. The compound can hybridize to a DNA template thereby defining the number of monomers assembled to a pore and thus the size of the formed pore. The DNA template can range from a unique single strand composed of multiple hybridization sites separated by flexible linkers to a complex rigid DNA nanoconstruct, such as a DNA origami-based ring, serving as a scaffold for pore formation. Hydrophilic modification at the transmembrane segment or terminus of the peptide provides long-lived pores and keeps the compound in a membrane-spanning conformation.
Claims
1. A hybrid pore-forming compound, comprising: a pore-forming peptide or protein having a first terminus and a second terminus, wherein a first oligonucleotide is linked to the first terminus, wherein the first oligonucleotide is derived from DNA, RNA, LNA, BNA, or PNA, wherein a first functional moiety is linked to the second terminus, and wherein the first functional moiety is hydrophilic.
2. The compound according to claim 1, wherein a second functional moiety is linked to a second oligonucleotide that is hybridized to the first oligonucleotide bonded to the first terminus of the peptide, wherein the second oligonucleotide is derived from DNA, RNA, LNA, BNA, or PNA, wherein the second functional moiety is a hydrophobic membrane binder, receptor, drug molecule, antibody, aptamer, metabolite, or fluorescent marker.
3. The compound according to claim 2, wherein the hydrophobic membrane binder is present and comprises a cholesterol moiety.
4. The compound according to claim 1, wherein the first functional moiety bonded to the second terminus of the peptide is a third oligonucleotide or fluorophore, wherein the third oligonucleotide is derived from DNA, RNA, LNA, BNA, or PNA.
5. The compound according to claim 1, wherein a template strand having a plurality of complementary hybridization sites is hybridized to a portion of the first oligonucleotide linked to the first terminus.
6. The compound according to claim 1, wherein a plurality of the pore-forming peptides or proteins are present with each first oligonucleotide linked to the first terminus hybridized to the template strand, such that the compound forms a larger pore.
7. The compound according to claim 1, wherein a plurality of the pore-forming peptide or proteins are present with each first oligonucleotide linked to the first terminus hybridized to the template strand such that the compound has a tetrameric, hexameric, octameric or dodecameric pore conformation.
8. The compound according to claim 1, wherein the pore-forming peptide is present and is Ceratotoxin A (CtxA).
9. The compound according to claim 1, wherein the first functional moiety is the third oligonucleotide, and wherein a second membrane binder is linked to the third oligonucleotide to aid in stabilizing a pore formed by the compound.
10. The compound according to claim 1, wherein the peptide or protein is functionalized differently at the first terminus as compared to the second terminus.
11. A method for forming the hybrid pore-forming compound according to claim 1, comprising the steps of: obtaining i) the pore-forming peptide or protein, ii) the first oligonucleotide and iii) the first functional moiety; and forming the pore-forming compound by self-assembly of i), ii), iii).
12. The method according to claim 11, further including the step of reacting in solution the template strand having a plurality of complimentary hybridization sites with an excess of the pore-forming compounds comprising the i), iii); removing excess unreacted pore-forming compounds, preferably by high pressure liquid chromatography.
13. The method according to claim 12, further including the step of hybridizing the first oligonucleotide to the second oligonucleotide, wherein the second oligonucleotide is present in an excess amount as compared to the first oligonucleotide.
14. A membrane, comprising a substrate and the compound according to claim 1, wherein the compound provides a pore between a first side of the substrate and a second side of the substrate.
15. The compound according to claim 1, wherein an extended, preferably rigid, nucleic acid nanostructure serves as a template for assembling a plurality of, pore formers into a pore, wherein the nucleic acid nanostructure contains the second functional moiety directly attached thereto, and wherein the nucleic acid nanostructure is a DNA origami structure or a single stranded tile assembly or a RNA origami structure.
16. The compound according to claim 3, wherein the first functional moiety bonded to the second terminus of the peptide is a third oligonucleotide or fluorophore, wherein the third oligonucleotide is derived from DNA, RNA, LNA, BNA, or PNA, and wherein a template strand having 4, 6, 8, or 12 complementary hybridization sites is hybridized to a portion of the first oligonucleotide linked to the first terminus.
17. The compound according to claim 16, wherein a plurality of the pore-forming peptides or proteins are present with each first oligonucleotide linked to the first terminus hybridized to the template strand, such that the compound forms a larger pore, or wherein a plurality of the pore-forming peptide or proteins are present with each first oligonucleotide linked to the first terminus hybridized to the template strand such that the compound has a tetrameric, hexameric, octameric or dodecameric pore conformation.
18. The compound according to claim 17, wherein the pore-forming peptide is present and is Ceratotoxin A (CtxA), wherein the first functional moiety is the third oligonucleotide, and wherein a second membrane binder is linked to the third oligonucleotide to aid in stabilizing a pore formed by the compound, and wherein the peptide or protein is functionalized differently at the first terminus as compared to the second terminus.
19. A method for forming the hybrid pore-forming compound according to claim 18, comprising the steps of: obtaining i) the pore-forming peptide or protein, ii) the first oligonucleotide and iii) the first functional moiety; and forming the pore-forming compound by self-assembly of i), ii), iii).
20. A membrane, comprising a substrate and the compound according to claim 18, wherein the compound provides a pore between a first side of the substrate and a second side of the substrate.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0036] The invention will be better understood and other features and advantages will become apparent by reading the detailed description of the invention, taken together with the drawings, wherein:
[0037]
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047]
[0048]
[0049]
[0050]
[0051]
[0052]
[0053]
[0054]
[0055]
[0056]
[0057]
DETAILED DESCRIPTION OF THE INVENTION
[0058] The invention encompasses hybrid pore-forming compounds comprising various functional groups that allow tailoring of pore size, stability and membrane affinity, among other benefits. The hybrid pore-forming compound comprises a peptide or protein having covalently attached nucleic acid oligonucleotides on both termini of the peptide or protein. Methods for making hybrid pore-forming compounds are straightforward. Many advantages are provided by the hybrid pore-forming compounds of the invention.
[0059] One particular advantage of the invention is the straightforward attachment of chemical modifications. The compounds presented here do not require further chemical synthesis and can be produced from off the shelf components.
[0060] In one embodiment, cholesterol is linked to the construct as a hydrophobic moiety to increase the affinity of the compound to a lipid bilayer of a membrane. Pore formation is observed at concentrations more than ten times lower than in absence of the cholesterol. The result was achieved without changing the peptide sequence which is one way to increase the potency of an antimicrobial peptide. However, if desired, peptide sequence can be modified as well.
[0061] Other modifications can be accomplished through hybridization to DNA strands with, by way of nonlimiting example, attached fluorescent markers, drug molecules, receptors, antibodies, aptamers, metabolites, etc. These modifications can be useful for drug delivery as well as targeted cell killing.
[0062] Modification of the peptide or protein by covalently attaching ligands to specific sites allows for the creation of biosensors. Such sensors based on resistive pulse sensing allow the detection of specific target molecules. Due to the modularity of the invention, additional functionalizations are straightforward to add or exchange.
[0063] An additional advantage provided by the hybrid pore-forming compounds is an increased lifetime of pores from peptides forming short-lived channels. Long-lived pores are required for resistive pulse sensing in order to allow collection of enough data for subsequent analysis. By providing hybrid compounds having long-lived pores efficiency of the molecule to kill pathogens cells or for drug delivery is increased.
[0064] As described herein, a single stranded DNA on the part of the peptide that is inserted into the membrane, which successfully increases the time during which the peptide is in a transmembrane conformation, namely from tens of milliseconds up to a few seconds or even several minutes.
[0065] Another important advantage of the compounds is the tailored pore size obtained by using DNA templates. The DNA template can range from a unique single strand composed of multiple hybridization sites separated by flexible linkers to complex rigid DNA nanoconstructs, such as a DNA origami-based ring, serving as a scaffold for pore formation. Rigid, large nanostructures used as templates, like the demonstrated origami ring, enable the formation of drastically larger peptide pores. Disclosed herein are simple “one pot” assembly of template structures with a large number of peptide monomer binding sites. The relatively rigid template disclosed leads to more stable peptide pores, as compared to a flexible template from double stranded DNA.
[0066] The compounds of the present invention offer specific benefits for resistive pulse sensing. For example, stable pores are provided, wherein pores are stable general for several minutes. Data analysis is impractical if in addition to translocation events, current fluctuations are caused by changes in the pore size. Increased affinity eases the formation of single pores. DNA assemblies allow simple tuning of the pore diameter and large pore diameters. Larger pores enabled by the compounds of the invention can be utilized to analyze larger target molecules.
[0067] The compounds of the invention also offer various benefits for targeted cell killing and drug delivery. The compounds are pore formers with increased affinity and are active at low concentrations. Pathogen-specific binding moieties, such as receptor binding moieties, antibodies, aptamers, etc. allow targeting selected cells, such as pathogen or other target cells. DNA assemblies in general allow for combination of several different binding motifs and stimulus response compounds with little effort. The compounds are useful for applications such as delivering macromolecules, such as siRNA, DNA, proteins, carbohydrates, etc., wherein minimum pore sizes are required, larger than the analyte size. Larger pores are also more efficient in killing cells because they disrupt cellular homeostasis.
[0068] The compounds of the present invention take advantage of the barrel-stave assembly mechanism of a pore-forming peptide, such as CtxA, to a pore, which is advantageous because various peptides such as CtxA are intrinsically able to form pores from a wide range of number of monomers and pore diameters.
[0069] When a peptide is used to create the compound that has an alpha-helical structure, such as CtxA, design flexibility is present for the assembly and reconfigurations, which can add functionality in order to stabilize the pores, for example. Typically, for instance in natural ion channel proteins, alpha helical proteins are more flexible and have more functionality than pores made from beta-sheet structures.
[0070] The compounds take advantage of a peptide that can be modified on its terminus, one or both of its C-terminus and N-terminus depending on the peptide utilized, without impeding its ability to self-assemble into well-defined pores. The C-terminus modification can be orthogonal in terms of chemical reactivity to the modification on the N-terminus, which means that both ends can be modified and functionalized differently with selective chemical reactions.
[0071] In an embodiment where the C-terminus modification of the peptide includes a thiol group (—SH), the compound is incorporated more readily into a membrane than a native peptide, such as CtxA, and assembles to pores, which demonstrates that the incorporation can be facilitated and controlled.
[0072] Chemical reactions of physical interactions of chemicals or reagents with the C-terminus of a peptide, such as CtxA, on the trans side of the membrane, i.e. the side opposite to the cis side where the compounds were added, can add functionality and stabilize the pores.
[0073] The hybrid pore-forming compounds take advantage of peptides that can self-incorporate into lipid or polymer membranes. Combination with a membrane is quite practical as methods for reconstitution into the membranes are not necessary.
[0074] When peptides such as CtxA are utilized, advantage of voltage-dependent incorporation can be used to form pores on demand, which also can be switched off on demand.
[0075] It is also been demonstrated herein that templating increases the local concentration of pore-forming peptides and therefore the probability of forming pores. This effect biases the assembly towards pores with large diameters. The compounds designed with a spacer strand, template strand, and short, flexible thymidine regions between these segments enables self-assembly of intended pore sizes reducing steric problems. Alternatively, neutral PEG linkers can be inserted. This is no small task since many alternative designs for templating may have steric constraints, low yield of complete assemblies and assemblies of inactive pores, etc.
[0076] The open design of the compound in a scaffold makes it possible to template and assemble pores without adding to the electrical resistance of the pore.
[0077] The assembly of pores can occur either before the experiments combined with purification of assembled pores or pore assembly can be carried out in situ by step-wise addition of the various components and molecules for the assembly. This flexibility in use of the molecules is advantageous to mitigate possible issues of limited solubility of either the individual components or the full assembly. Sequential, in-situ assembly from one or both sides of the membrane) also makes it possible to assemble pores with complex functionality.
[0078] For example, various pore-forming peptides are suitable for use in the present invention. Examples include, but are not limited to, ceratotoxin A, alamethicin, MelP5, melittin, magainin, cecropin, etc., or any synthetically evolved variant of these peptides. Preferably, pore-forming peptides that do not contain post-translational modifications or unnatural amino acids can be used, as they are simple to synthesize and to modify chemically to attach the DNA oligonucleotides.
[0079] Oligonucleotide can be made of nucleotide sequences including but not limiting to DNA, RNA, PNA, LNA, BNA, as well as unnatural nucleic acids. N-terminus oligonucleotides devoid of spacer region could be used, although the template should have a different geometry to account for steric hindrance. Such templates could present longer linkers between each hybridization site, while presenting hydrophobic moieties, receptors, etc. directly to the membrane surface. In another variant, multiple pore-forming peptides could bind to one oligonucleotide, allowing to multiply the number of monomers in a pore while keeping the template strand short.
[0080] The moieties on the spacer strand can be anchoring moieties such as diacyl chains, cholesterol, receptor-binding agents, aptamers, antibodies, metabolites, etc. These moieties can also be elements enhancing the detection of the construct like fluorescent dyes, proteins (or genes encoding for them) or aptamers, metabolic nanoparticles, radioactive markers, quantum dots, etc.
[0081] Pore formation and disassembly can be triggered by chemical, mechanical, light or other signals mediated by the DNA hybridization (toehold mediated strand displacement, light-switchable bases, aptamers, etc).
[0082] C-terminus moieties can be added to obtain long-lived pores. These moieties are hydrophilic or become hydrophilic once reaching the trans side of the membrane (for example due to pH change). These groups can be oligonucleotide sequences (DNA, RNA, PNA, LNA, BNA, as well as unnatural nucleic acids), amino acids or any other hydrophilic group (thiol, azide, biotin, etc.). The anchoring can also be realized by templating the pore-forming peptides on the trans side of the membrane.
[0083] The membrane can be a lipid membrane (phospholipid membrane, archaea membrane, etc.), a synthetic membrane (block copolymer, etc.), can be charged, uncharged or zwitterionic. The pore can also be employed for forming solid-state hybrid pores. Therefore, the pore is inserted into an existing solid-state nanopore to change its properties.
[0084] Here we describe a modular DNA-assembly system based on Ceratotoxin A (CtxA) peptides, for increased membrane affinity, geometrical arrangement of monomers and increased pore lifetime. Like alamethicin, the 36-amino acid peptide CtxA forms short, barrel-stave pores that increase or shrink in diameter as a consequence of association or dissociation of peptide monomers. To this end, we covalently link ssDNA to the N-terminus of CtxA peptides for hybridization of complementary oligonucleotide sequences.
[0085] Linking the peptide-DNA hybrid to DNA-coupled hydrophobic moieties increases membrane affinity. By adding a templating DNA strand with a defined number of binding sites, we bias the pore diameter towards 4-, 6-, 8- or 12-mer assemblies. We demonstrate that the introduction of a hydrophilic DNA domain on the C-terminus side of CtxA, part that is thought to insert into the lipid bilayer.sup.1, stabilizes the hybrid monomers in a bilayer-spanning conformation. This modification turns short-lived CtxA pores with dynamically fluctuating diameters into long-lasting pores with well-defined diameters, which could be beneficial for sensing applications.
[0086] One feature of this construct is the absence of solid, ion-blocking structures, similar to the large αHL cap domain containing a vestibule. In contrast, the assembly we present is a short membrane-spanning channel, geometrically arranged by a loosely packed, open DNA structure, that circumvents additional contributions to resistance from a vestibule or a tightly packed templating structure. Additional distinct advantages of this minimalistic design of an artificial ion channel are the use of solid-phase synthesis of all components with the potential for large-scale production and the possibility to modify the sequence and number of amino acids of the peptide at any position with great flexibility for high-throughput screening. DNA-assembled peptide pores could also be used for applications other than sensing, such as drug delivery or targeted killing of pathogens.
[0087] Results and Discussion
[0088] Assembly of CtxA-DNA hybrid constructs. We design a new peptide-DNA hybrid based on the 36-amino acid peptide CtxA. A 55-base long ssDNA oligonucleotide is attached with its 5′ end to the N-terminus side of the peptide, as shown in
[0089] To obtain a more rigid and more defined DNA template, we constructed a ring-shaped origami structure with a diameter of 33.4 nm (inner diameter 20.6 nm). The ring was formed by bending the DNA helices to a circle. A 82×15×11 nm block structure is connected to the ring. The block does not serve the pore assembly but uses up the remaining scaffold to avoid an influence of a large single stranded DNA loop in close vicinity to the pore. 20 staples distributed on the bottom side of the ring carry extensions, ready to hybridize DNA conjugated peptides with a 20 nucleotide-long complementary attachment sequence (instead of the 55-base-long sequence of the other design). As a 20-meric peptide would form a much smaller pore of approximately 8.7 nm diameter, linkers are required. Therefore, peptide-DNA conjugates are hybridized in a distal conformation to the structure with the connecting DNA duplex acting as a 6.1 nm linker between origami structure and peptide. Two additional thymine bases were inserted on both sides of this double stranded attachment, serving as flexible linkers. To further avoid steric and electrostatic repulsion of the double stranded DNA linkers that might impede peptide pore assembly, we connected the peptide via an uncharged PEG linker to the attachment oligonucleotide. Alternatively, a strand carrying two reactive DBCO groups attached via a PEG linker was used to form up to 40-meric peptide pores.
[0090] Similar to the previously described design, additional functional moieties can easily be attached via staple extensions. We added eight further extensions with an orthogonal attachment sequence to the bottom of the ring that can carry cholesterol moieties to increase the membrane affinity of the origami structures to the membrane.
[0091] We use the CtxA peptide for this study as pores assembled from small peptides have attractive characteristics such as forming barrel-stave pores with well-defined conductance levels, and forming channels with a pore length ≤5 nm, potentially increasing the resolution of sensing applications. Its low molecular weight allows large-scale synthesis of the peptide as well as chemically functionalizing the peptide. Moreover, as the peptide is positively charged, it readily binds stronger to the negatively charged outer membranes of many pathogens compared to mammalian cells. This feature makes CtxA-based pore assemblies attractive for targeted cell killing applications
[0092]
[0093] Hydrophobic functionalization for increased pore forming activity. We introduce a cholesterol moiety to increase the affinity of the DNA-assembled peptide pore to the membrane.
[0094] These results indicate that N-terminal dsDNA modification of the CtxA peptide does not inhibit its insertion in membranes but rather favors it when this modification exposes a hydrophobic group. Moreover, the conductance behavior of the resulting pores is also very similar to the one from native CtxA, with values increasing non-linearly, with the pore size. In addition to this non-linear increase in conductance, the zoom of the current trace induced by Chol-dsDNA-CtxA, shown in
[0095] While a minimum concentration of 10-20 nM is required for native CtxA to display significant pore formation, concentrations as low as 1 nM are sufficient to observe frequent pore formation events by Chol-dsDNA-CtxA.
[0096] Interestingly, control experiments with ssDNA-CtxA added at concentrations above 10 nM produce ill-defined conductance fluctuations instead of the usual well-defined behavior of native CtxA (
TABLE-US-00001 TABLE 1 Comparison of the open state conductance values for native CtxA and Chol-dsDNA-CtxA, measured at an applied potential difference of +180 mV. Conductance (pS) Chol-dsDNA- Area-equivalent Open states Native CtxA CtxA diameter (nm).sup.b O1 (3-mer) 50 ± 25 35 ± 20 0.1 ± 0.1 O2 (4-mer) 510 ± 30 445 ± 155 0.5 ± 0.3 O3 (5-mer) 1645 ± 200 1515 ± 320 1.0 ± 0.4 O4 (6-mer) 3125 ± 305 3100 ± 170 1.4 ± 0.3 O5 (7-mer) 4630 ± — 5200 ± 600 1.9 ± 0.6 O6 (8-mer) 6600 ± — 6960 ± 120 2.3 ± 0.3 O7 (9-mer) 9500 ± 400 2.8 ± 0.5 O8 (10-mer) 11640.sup.a 3.3 ± — O9 (11-mer) 14140.sup.a 3.8 O10 (12-mer) 16760.sup.a 4.3 .sup.aThe conductance values of O8 to O10 are extrapolated from a fitting function to the experimental data of the first 7 open states. This function assumes a geometrical arrangement of the monomers, a peptide diameter of 1.2 nm and a pore length of 2.7-4 nm. .sup.bThe diameter is estimated based on the measured and extrapolated conductance values G of Chol-dsDNA-CtxA. Errors are calculated from standard deviation of the mean. The equation we used was shown by Cruickshank et al., Biophysical Journal 73, 1925-1931 (1997) and takes into account two access resistances (one for entrance and one for exiting the pore) and the channel resistance:
[0097] Table 1 shows that the conductance values of the first six open states (O1 to O6) for native CtxA and Chol-dsDNA-CtxA are not significantly different (paired-sample t-test, p=0.36). This result implies that the addition of dsDNA on the N-terminal side of CtxA does not significantly change the diameter of the formed pores.
[0098] Conventionally, pore-forming peptides are engineered by modifying the amino acid sequence of peptides to increase their pore-forming activity at low concentrations.sup.3-5. We show here that the addition of DNA strands with hydrophobic cholesterol moieties achieves the same effect without the need for sequence alterations, which will affect peptide function.
[0099] Formation of pores with defined sizes by DNA templating.
[0100] Further exploring the potential of combining a DNA strand and a pore-forming peptide, we introduce a DNA template strand consisting of a repeating sequence, complementary to the template-binding region sequence of CtxA-DNA. We aim to form pores comprised of a defined and constant number of monomers that compares to the number of hybridization sites on the template. To demonstrate feasibility, we show the influence of template strands containing four, six, eight or twelve hybridization sites for CtxA-DNA (‘4-mer template’, ‘6-mer template’, ‘8-mer template’ and ‘12-mer template’). As shown in Table 1, such tetra-, hexa-, octa- and dodecameric assemblies result in pores with 0.5±0.3, 1.4±0.4, 2.3±0.5 nm and 3.9±0.5 nm diameter, based on the measured O2, O4, and O6 conductance values of the Chol-dsDNA-CtxA and an extrapolation of these measured values to find an estimated O10 conductance value.
[0101]
[0102] Dynamic fluctuations of pore diameters however still occurred (
[0103] Further increasing the length of the template to eight or twelve hybridization sites allows the formation of larger pores. We show a two-second recording of such an octameric assembly in
[0104] While the current traces we show in
[0105] We compare in
[0106] In addition to biasing the size of the formed pores towards the desired size, the presence of a template strand also leads to an increased pore formation at lower concentration than without the template. In close to 50% of the experiments, addition of the 8-mer template results in incorporation of many pores in parallel, sometimes exceeding the amplifiers current limit (˜16 nA). We present in
[0107] Formation of pores with defined sizes by DNA templating.
[0108] For the assembly of size tuneable pores for resistive pulse sensing, discrete and well-defined DNA objects are required. By employing several partly complementary strands, only flexible constructs with limited complexity can be formed as shown by two recent papers from Henning-Knechtel et al..sup.7 and Spruijt et al..sup.6. In contrast, the DNA origami technique allows the assembly of large, relatively rigid and geometrically well-defined templates with desired shape and atomistic precision. Readily available tools for simple design, production and purification ease the development of these macromolecular constructs. Consisting of one scaffold strand of about 8000 bases and about 200 staples, origami structures can provide a large number of attachment sites for pore formers and other functional groups, for example by affinity moieties, enhancing binding to membranes or moieties to capture target analytes for enhanced detection. Similar extended nucleic acid structures can also be obtained using other methods like single stranded tile assembly or RNA origami.sup.8,9.
[0109] We estimated the number of monomers in a pore extrapolated with a polynomial fit to the experiments data from the conductance value of the first six open states of native CtxA.
[0110] Hydrophilic modification of the CtxA on the C-terminus results in long-lived open states.
[0111] Applications such as sensing require long-lived, stable pores in lipid or polymer membranes. To design CtxA-DNA hybrids that form longer-lasting pores, we added an additional hydrophilic segment consisting of 12 thymine bases to the C-terminal part of the peptide, yielding a CtxA covalently attached on both ends to a DNA strand. We hypothesized that this segment might trap CtxA in a transmembrane conformation once the C-terminal section is transmembrane. This transmembrane DNA sequence allows hybridization of a complementary 12 adenine-bases oligonucleotide that is added on the trans side of the membrane. After hybridization, this double stranded segment is even less likely to flip back to the cis side of the membrane and potentially further stabilizing the pore. Modifying this 12 adenine-based oligonucleotide with a cholesterol moiety could anchor the polyA sequence to the bilayer, increasing the probability for hybridization to the 12 thymine bases of the C-terminal part of the peptide.
[0112]
[0113] To explore programmed assembly of CtxA peptides with C-terminal T.sub.12 modification to long-lived pores of the desired size, we repeated the experiments with an 8-mer template (
[0114] Altogether, these results support the hypothesis that the hydrophilic C-terminal modification with T.sub.12 stabilized the peptides in their transmembrane conformation. Adding a template strand additionally allowed defining the size of the pores. Modifying the transmembrane part of the CtxA peptide, hence provides a strategy for prolonging the open state of pores from pore-forming peptides, which otherwise fluctuate dynamically between conductance levels.
[0115] Taking advantage of the T.sub.12 tail present on the trans side of the membrane, we designed another oligonucleotide sequence possessing two hybridization regions, one to bind to the template and the other one to bind to the T.sub.12 tail of CtxA. We first prepared and purified structures composed of an 8-mer template and eight of these new oligonucleotide sequences (see
[0116] By modifying the transmembrane part of the CtxA peptide, we provide a pathway for formation of long-lived pores, from pore-forming peptides which otherwise lead to dynamic fluctuations between conductance levels.
[0117] After obtaining long-lived and stable pores, we added a mixture of analytes (PEG 4000, PEG 1500, PEG 200 and Dextrane Sulfate 8000, with final concentrations of 461 μM, 922 μM, 69 μM and 31 μM respectively) on the compartments on both sides of the membrane. We show in
[0118] Assembling CtxA pores with the 4-mer, 6-mer, 8-mer or 12-mer templates prevented the replication of cancer cells at lower concentrations than native CtxA.
[0119] DNA templating of CtxA pores could serve to enhance toxicity of pores in applications of targeted cell killing. Biologically, the antimicrobial peptide CtxA is produced by the Medfly Ceratitis capitata, in order to protect its eggs.sup.10. As cytotoxicity of pore-forming antimicrobial peptides correlates with pore size and pep-tide concentration.sup.11, we hypothesized that templating CtxA would kill pathogen or cancer cells at lower concentrations than native CtxA, because templating results in a high local concentration and in larger pores than non-templated CtxA.sup.11.
[0120] To investigate the cytotoxic activity of templated DNA-peptides, we monitored the growth of the epithelial lung cancer cell line A549 upon addition of 4-mer, 6-mer, 8-mer or 12-mer templated CtxA peptides compared to adding native CtxA as control. As a metric for cell viability, we determined the change in confluence over time for each peptide concentration.
CONCLUSION
[0121] A modular assembly platform based on the 36-amino acid pore-forming peptide CtxA using DNA nanotechnology is disclosed. Covalently linking the peptide to a single-stranded DNA oligonucleotide also allows simple functionalization of the peptide-DNA hybrid with a cholesterol-bearing DNA strand, drastically increasing the peptide's affinity to the membrane as well as its propensity to form well-defined conductance states. Employing DNA template strands with a defined number of binding sites for the DNA-modified peptide monomers preferentially leads to pores of predefined size. We demonstrate tetrameric, hexameric, octameric and dodecameric assemblies with estimated inner diameters ranging from approximately 0.5 to 3.9 nm based on the conductance values. While these templated assemblies still formed short-lived pores like native CtxA, the addition of a hydrophilic DNA domain to the transmembrane side of the CtxA peptide traps the peptide monomers in a membrane-spanning conformation. This modification results in long-lived pore formation, which can last as long as 30 minutes at one stable and constant conductance level. Alternatively, rigid DNA origami structures allowed templating more monomers (up to 40 in this presented attempt) and thus forming larger pores. These origami pores were also stable for longer times than native CtxA, reaching open pore duration of more than 80 minutes.
[0122] DNA-mediated assembly of pore-forming peptides provides several distinct advantages compared to pores traditionally used in nanopore sensing: (i) sub-nanometer fine-tuning of the pore diameter with single monomer increments by using templating structures, (ii) the presence of a loose and open DNA-based frame, without additional resistance caused by a vestibule, (iii) sequence-specific orthogonal hybridization chemistry for targeting defined positions in the structure, (iv) straight-forward design with three different species, (v) potential to open new pathways for adding specific functions such as receptors, antibodies or aptamers, and (vi), possibility to kill cancer cells at more than 20-fold lower total peptide concentrations compared to non-templated CtxA peptides. This result, in principle, makes it possible to use the addition of a DNA template to trigger pore formation in situ by using a DNA-CtxA peptide concentration that is too low for killing before addition of the template. Future extensions of this work may target specific cell types.sup.12, pathogens or analytes by hybridizing ssDNA-tagged ligands, antibodies or aptamers to the construct.
[0123] In summary, DNA engineering of CtxA monomers with a straight-forward design makes it possible to form long-lasting, well-defined pores with constant single-channel conductance that can potentially be useful for sensing, drug delivery and pathogen cell killing applications.
[0124] Methods
[0125] DNA-Modified Peptides Preparation
[0126] The compounds are commercially synthesized from a CtxA derivative bearing the DNA oligonucleotide (ssDNA-CtxA) or reacted in-house. Therefore, an CtxA containing an azide group (Azide-CtxA) on its N-terminus reacts overnight via click-chemistry to dibenzocyclooctyne (DBCO)-containing oligonucleotide of the desired sequence. CtxA with a hydrophilic tail is formed from ssDNA-CtxA modified with an azide group on its C-terminus (ssDNA-CtxA-Azide) or with an Azide-CtxA having a thiol group on its C-terminus (Azide-CtxA-Thiol). ssDNA-CtxA-Azide and Azide-CtxA-Thiol then react with an excess 12T-DBCO or 12T-maleimide to form ssDNA-CtxA-12T. High Pressure Liquid Chromatography (HPLC) is then used to remove the excess, unreacted species, ssDNA-CtxA-12T monomers are added in large excess to a solution containing the template strand and HPLC is used to collect the full assemblies and remove the excess ssDNA-CtxA-12T monomers. We confirmed the successful conjugations by HPLC peptide mapping, SEC or SAX. The chemicals were solubilized either in pure water or in TE buffer.
[0127] Lipids Preparation/Planar Lipid Bilayer Formation
[0128] The lipid composition for the bilayers consisted of POPC, DOPE and POPS with a 7:3:1 (w/w) ratio (PC/PE/PS) or for the origami structures in diphytanoyl phosphatidylcholine (DiPhyPC). We dissolved the resulting lipid mixture in pentane (total lipid concentration: 10 mg/mL). The buffered electrolyte solution consisted of 1M NaCl, 10 mM HEPES, pH 7.4 or 3M CsCl, 10 mM HEPES, pH 7.4 in 30% glycerol.
[0129] We designed Teflon chambers with one big compartment (containing a maximum volume of 1.5 mL) and one small compartment (containing a maximum volume of 200 μL). We pretreated Teflon films (Eastern Scientific LLC, Rockville, Md.) with apertures of 50 μm by pipetting 1 μL of pre-treatment solution—hexadecane in hexane 2.5% (v/v)—onto both sides of the aperture of the Teflon film. We then mounted the Teflon film in a Teflon chamber using high-vacuum grease (Dow Corning Corporation), separating the two compartments of the Teflon chamber. The only connection between the compartments was the aperture in the Teflon film over which we formed virtually solvent-free planar lipid bilayers using the technique described by Montal and Mueller.sup.10. Briefly, we added electrolyte solution to both compartments (1.2 mL in the bigger compartment and 160 μL for the smaller one) and spread 1-2 μL of lipid solution onto the surface of the buffered electrolyte solution. After the solvent evaporated, a lipid monolayer (Langmuir film) formed at the air-water interface. We raised and lowered the electrolyte solution until we measured a baseline current (−3 pA<|<3 pA) indicating that a bilayer had formed. We then thinned the membrane by lowering and raising the electrolyte solution in one compartment, until we measured a capacitance of 60±10 pF. To monitor capacitance, we applied a triangular voltage and the capacitance was either calculated by the amplifier or determined visually using the manual capacitance compensation of the amplifier. Prior to adding the peptide, we checked the stability of the bilayer (absence of leak currents, expected noise level) by applying transmembrane voltages of up to 200 mV for 5 min at both polarities. We used one of two different amplifiers, an EPC7 (HEKA Instruments Inc., Holliston, Mass., USA) or a BC-535 (Warner Instruments Hamden, Conn., USA)) and connected both compartments to the amplifier through two Ag/AgCl pellet electrodes (Warner Instruments Hamden, Conn., USA). We placed the Teflon chambers inside Faraday cages, on BM4 vibration isolation platforms (Minus K® Technology, Inc., Inglewood, Calif., USA). We carried out all experiments at room temperature (22±1° C.) and tested all setups with different model cells to confirm proper functionality of the amplifiers and function generators. We sampled currents at 50 kHz and low-pass 10 kHz. We analysed data using OriginLab (OriginLab Corporation, Northampton, Mass., USA) and pClamp (Molecular Devices, Sunnyvale, Calif., USA) software.
[0130] Flexible Template Experiments
[0131] We performed the experiments with the peptide-DNA hybrid in two different ways: (i) we added all components sequentially—ssDNA-CtxA first, then the template strands, one after the other—or (ii) we mixed the ssDNA-CtxA with the spacer strand (with or without cholesterol) and the template strand in a DNA LoBind tube (Eppendorf Tubes, Hamburg, Germany) and let them react overnight at room temperature (pre-incubation experiments). We also performed the pre-incubation experiments with and without HPLC-SEC purification. In the case of unpurified assemblies, we added the DNA-modified peptides and the spacer strand stoichiometrically and then added the n-mer template (with n equal to 4, 6 or 8) at a ratio of 1 mole for n moles of DNA-modified peptide. When purifying the assemblies, we added the peptide-DNA monomers in excess compared to the template strand (at least 5 n moles of peptide for 1 mol of n-mer template) and removed the excess monomers using HPLC-SEC purification (Agilent SEC 3 column, 300 mm, 300 nm pore size, 4.6 mm internal diameter). We then stored the collected assemblies at +4° C. for later use and add the spacer strand in excess prior to the experiment. When a cholesterol moiety is bound to the spacer strand, we heat the strand for 5 minutes at +60° C. to avoid aggregation of the cholesterol moieties. For the experiments with sequential addition, we added the various components at concentrations in the nanomolar range, while for pre-incubation experiments, we added all the components in micromolar concentrations and later diluted the samples prior to adding them to the buffered electrolyte solution.
[0132] Origami Structure Assembly Protocol
[0133] To fold the origami structures, we mixed 50 nM scaffold with a 4-fold molar excess of staple strands in a 20 mM MgCl.sub.2 solution containing TE buffer. We heated the structures to 90° C. and cooled them down slowly from 57° C. to 49° C. within 18 hours. Subsequently, we removed the excess staples from the folded structure by PEG precipitation as described elsewhere.sup.11. Within the PEG purification, we changed the buffer to TE containing 1M NaCl.
[0134] For attachment of CtxA to the origami constructs, we added the peptide-oligonucleotide conjugates to the structures with a five times molar excess and incubated for at least one hour at room temperature. We finally removed unbound peptides and peptide-DNA conjugates by HPLC size exclusion chromatography (Agilent SEC 3 column, 300 mm, 300 nm pore size, 4.6 mm internal diameter).
[0135] We heated the cholesterol oligonucleotides to 60° C. for 5 minutes before attachment to the origami structures. When required, we added the cholesterol strands with a final concentration of 1 μM to the origami constructs directly before use, without further purification.
[0136] Cell Culture Experiments.
[0137] We grew lung epithelial A549 cells in RPMI 1640 medium containing 25 mM HEPES, 1% L-glutamine, 10% fetal bovine serum and added 1% penicillin-streptomycin for prevention of bacterial contamination of cell cultures. We seeded the cells in 96-well plates (TPP, Trasadingen, Switzerland) with 10′000 cells per well, in a total volume of 50 uL per well. We placed the plates in the IncuCyte Zoom imaging system (Essen Bioscience, Ann Arbor, Mich., USA) placed inside of an incubator set to 37° C. and 5% CO2 and monitored the growth of the cell by monitoring the change in confluence over time. We seeded the cells and left them to adhere and replicate for 20 h before adding the templated CtxA-DNA assemblies or native CtxA as control. We then measured the cell confluence every 2 h. To estimate the effect of the different peptide assemblies on the change in confluence over time, we fitted the observed confluence levels after peptide addition linearly.
[0138] DNA and Amino Acid Sequences
[0139]
[0140] CtxA's amino acid sequence is shown in SEQ ID N01.
[0141] The nucleotide sequences of the oligonucleotides used with the flexible templates and shown in SEQ ID NO2 to 4.
[0142] Sequences are provided from 5′ to 3′ as generated from the design software cadnano.
[0143] The sequences of the block component staples are shown in SEQ ID NO5 to 148. The sequences of the unmodified ring staples are shown in SEQ ID NO149 to 165. The cholesterol strand sequence and the sequence of the strand used to attach the CtxA peptides are shown in SEQ ID NO166 and 167. The sequences of the peptide attachment sites are shown in SEQ ID NO168 to 188. The sequences of the cholesterol attachment sites are shown in SEQ ID NO189 to 196. The scaffold sequence is shown in SEQ ID NO197.
[0144] For the avoidance of doubt, the compositions of the present invention encompass all possible combinations of the components, including various ranges of said components, disclosed herein. It is further noted that the term “comprising” does not exclude the presence of other elements. However, it is to also be understood that a description of a product or composition comprising certain components also discloses a product consisting of said components. Similarly, it is also to be understood that a description of a process comprising certain steps also discloses a process consisting of the steps.
[0145] In accordance with the patent statutes, the best mode and preferred embodiment have been set forth; the scope of the invention is not limited thereto, but rather by the scope of the attached claims.
REFERENCES
[0146] 1 Langecker, M. et al. Synthetic lipid membrane channels formed by designed DNA nanostructures. Science 338, 932-936, doi:10.1126/science.1225624 (2012). [0147] 2 Krishnan, S. et al. Molecular transport through large-diameter DNA nanopores. Nat Commun 7, 12787, doi:10.1038/ncomms12787 (2016). [0148] 3 Burns, J. R., Stulz, E. & Howorka, S. Self-assembled DNA nanopores that span lipid bilayers. Nano Lett 13, 2351-2356, doi:10.1021/n1304147f (2013). [0149] 4 Burns, J. R. et al. Lipid-bilayer-spanning DNA nanopores with a bifunctional porphyrin anchor. Angewandte Chemie (International ed. in English) 52, 12069-12072, doi:10.100.sup.2/anie.201305765 (2013). [0150] 5 Burns, J. R., Seifert, A., Fertig, N. & Howorka, S. A biomimetic DNA-based channel for the ligand-controlled transport of charged molecular cargo across a biological membrane. Nature Nanotechnology 11, 152, doi:10.1038/nnano.2015.279 https://www.nature.com/articles/nnano.2015.279#supplementary-information (2016). [0151] 6 Spruijt, E., Tusk, S. E. & Bayley, H. DNA scaffolds support stable and uniform peptide nanopores. Nature Nanotechnology, doi:10.1038/s41565-018-0139-6 (2018). [0152] 7 Henning-Knechtel, A., Knechtel, J. & Magzoub, M. DNA-assisted oligomerization of pore-forming toxin monomers into precisely-controlled protein channels. Nucleic Acids Research, gkx990-gkx990, doi:10.1093/nar/gkx990 (2017). [0153] 8 Ke, Y., Ong, L. L., Shih, W. M. & Yin, P. Three-Dimensional Structures Self-Assembled from DNA Bricks. Science 338, 1177-1183, doi:10.1126/science.1227268 (2012). [0154] 9 Wei, B., Dai, M. & Yin, P. Complex shapes self-assembled from single-stranded DNA tiles. Nature 485, 623, doi:10.1038/nature11075 https://wvvw.nature.com/articles/nature11075#supplementary-information (2012). [0155] 10 Marchini, D., Marri, L., Rosetto, M., Manetti, A. G. & Dallai, R. Presence of Antibacterial Peptides on the Laid Egg Chorion of the Medfly Ceratitis capitata. Biochemical and biophysical research communications 240, 657-663 (1997). [0156] 11 Saint, N., Marri, L., Marchini, D. & Molle, G. The antibacterial peptide ceratotoxin A displays alamethicin-like behavior in lipid bilayers. Peptides 24, 1779-1784, doi:http://dx.doi.orq/10.1016/j.peptides.2003.09.015 (2003). [0157] 12 Majd, S. et al. Applications of biological pores in nanomedicine, sensing, and nanoelectronics. Current Opinion in Biotechnology 21, 439-476, doi:http://dx.doi.orq/10.1016/j.copbio.2010.05.002 (2010). [0158] 13 Montal, M. & Mueller, P. Formation of bimolecular membranes from lipid monolayers and a study of their electrical properties. Proceedings of the National Academy of Sciences 69, 3561-3566 (1972). [0159] 14 Stahl, E., Martin, T. G., Praetorius, F. & Dietz, H. Facile and Scalable Preparation of Pure and Dense DNA Origami Solutions. Angewandte Chemie International Edition 53, 12735-12740, doi:doi:10.1002/anie.201405991 (2014).